Table 1.

Inappropriate medication criteria excluded from the analysis

Excluded from the criteria independent of disease or condition:
Because the drugs were unavailable in Japan
Propoxyphene	Hyoscyamine
Trimethobenzamide	Tripelennamine
Carisoprodol	Dexchlorpheniramine
Medaxalone	Cyclandelate
Cyclobenzaprine	Meperidine
Chlordiazepoxide-amitriptyline	Ketorolac
Perphenazine-amitriptyline	Daily fluoxetine
Doxepine	Orphenadrine
Meprobamate	Guanethidine
Oxazepam	Guanadrel
Temazepam	Nitrofurantoin
Clidinium-chlordiazepoxide	Mesoridazine
Halazepam	Mineral oil
Chlorazepate	Amphetamines (excluding methylphenidate hydrochloride and anorexics)
Because long-term use could not be tracked
Long-term use of full-dosage, longer-half life, non-COX-selective NSAIDs
Long-term use of stimulant laxatives
Excluded from the criteria dependent on disease or condition:
Because the drug was unavailable in Japan
Seizure disorder (Bupropion was unavailable.)
Because the patients with these disease or conditions could not be identified
Gastric or duodenal ulcers	SIADH/hyponatremia
Bladder outflow obstruction